Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Merck's Exit Highlights UK Risks Losing Pharma Investment Amid Rising Costs - Merck & Co (NYSE:MRK)

Summary by Benzinga
Pharmaceutical companies are pulling investment from the UK as NHS drug spending falls and pricing disputes worsen.

2 Articles

BenzingaBenzinga
Center

Merck's Exit Highlights UK Risks Losing Pharma Investment Amid Rising Costs - Merck & Co (NYSE:MRK)

Pharmaceutical companies are pulling investment from the UK as NHS drug spending falls and pricing disputes worsen.

·New York, United States
Read Full Article
BizTocBizToc

Big pharma will stop investing in UK, warns eminent scientist Sir John Bell

Warning follows news of US drugmaker Merck’s decision to scrap planned £1bn London research centre Sir John Bell, a prominent scientist who brought business and government together during the Covid-19 vaccine rollout, has warned that other big pharmaceutical companies will stop investing in the…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

BizToc broke the news in on Thursday, September 11, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Merck icon

Merck

NHS icon

NHS

Coronavirus icon

Coronavirus

Pharma icon

Pharma

United Kingdom icon

United Kingdom

News
For You
SearchBlindspotLocal